Jan 29, 2025, 21:39
Endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer
Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared an article by Geoffrey Ku et al. on X:
“NRG GI-007
LA-Esophagus Carcinoma
dCRT (50.4 Gy/28 fx carbo/taxol) + endoscopically injected oncolytic virus OBP-301
- cCR rate
- Comparatively favorable AE profile
Brilliant work and looking forward to future study!!”
NRG-GI007: Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer.
Authors: Geoffrey Yuyat Ku, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 29, 2025, 21:39
Jan 29, 2025, 21:39
Jan 29, 2025, 21:39
Jan 29, 2025, 18:58
Jan 29, 2025, 18:53
Jan 29, 2025, 18:50
Jan 29, 2025, 18:47